课题基金 / 基金详情

Functional Study of Sarcoglycan in Cardiomyopathic Muscle Cells

Functional Study of Sarcoglycan in Cardiomyopathic Muscle Cells
心肌病肌细胞中肌聚糖的功能研究
批准号:
12670718
负责人:
IWATA Yuko
金额:
$2.11万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

IWATA Yuko的其他基金

相似基金

相关文献

中文摘要
翻译
delta-sarcoglycan(肌营养不良蛋白-糖蛋白复合物的一种成分)的缺乏会导致BIO14.6仓鼠心肌病和骨骼肌营养不良。利用正常和BIO14.6仓鼠(30-40日龄)的肌肉培养肌管(培养2-4天),研究了δ肌聚糖参与钙代谢的可能性,并最终导致肌细胞损伤。免疫印迹分析显示,与细胞钙处理有关的l型钙通道、ryanodine受体、SR-CaATPase、Na/Ca交换器等膜蛋白含量在对照组和BI014.6肌管之间无显著差异。在静息条件下,Ca^<2+>内流进入BIO14.6肌管2+显著高于对照组(5分钟时高达1.8倍),表明Ca^<2+>内流在BIO14.6肌管中被激活。当这些细胞被置于高达20%的循环伸长1h时,仅在BIO14.6肌管中观察到肌酸磷酸激酶(CK)释放到培养基中的显著增加。100μM GdCl_3降低了^<45>Ca^<2+>内流和CK释放。使用2+腺病毒载体转染δ肌聚糖也可以挽救异常的钙代谢和CK释放。静息时肌管中钙内流的增加可能是由于在这些肌管中检测到的拉伸激活阳离子通道的基础活性增加,这些结果提示了这种肌营养不良动物模型中细胞损伤的可能机制。
英文摘要
Deficiency of delta-sarcoglycan, a component of the dystrophin-glycoprotein complex, causes cardiomyopathy and skeletal muscle dystrophy in BIO14.6 hamsters. Using cultured myotubes (for 2-4 days) prepared from muscle of normal and BIO14.6 hamsters (30-40 day old), we investigated the possibility that the delta-sarcoglycan in calcium metabolism which may ultimately leads to myocyte damage. Immunoblot analysis revealed that the contents of membrane proteins involved in cell Ca handling such as L-type Ca channel, ryanodine receptor, SR-CaATPase, Na/Ca exchanger were not different between control and BI014.6 myotubes. ^<45>Ca^<2+> influx into BIO14.6 myotubes 2+ under resting conditions was significantly higher (up to1.8-fold at 5 min) than in controls, suggesting that Ca^<2+> influx is activated in BIO 14.6 myotubes. When these cells were subjected to cyclic elongation of up to 20 % for 1h, a marked increase in creatine phosphokinase (CK) release into the medium was obsereved in only BIO14.6 myotubes. 100μM GdCl_3 reduced ^<45>Ca^<2+> influx and CK release. Transfection of delta sarcoglycan using 2+ adenovirus vector also rescue abnormal calcium metabolism and CK release The increased resting Ca influx in BIO14.6 myotubes may be due to the increased basal activity of stretch-activated cation channels detected in these myotubes and these results suggest a possible mechanism for cell damage in this animal model of muscular dystrophy.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
岩田裕子: "Stretch-activated cation-permeable channels are activated in cultured myotubes from skeletal muscle of sarcoglycan deficient hamster."Am.J.Phys.. (2001)
Yuko Iwata:“在肌聚糖缺陷仓鼠的骨骼肌培养的肌管中,拉伸激活的阳离子渗透通道被激活。”Am.J.Phys.. (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Katanosaka, Y., et al.: "Isolation and characterization of myotubes from BIO14.6 hamsters"Journal of Molecular and Cellular Cardiology. 33. A56 (2001)
Katanosaka, Y. 等人:“BIO14.6 仓鼠肌管的分离和表征”分子和细胞心脏病学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Iwata, Y., et al: "Functional role of syntophin as an actin -binding protein"Cardiac structure and function. 23. 219-228 (2001)
Iwata, Y. 等人:“合成蛋白作为肌动蛋白结合蛋白的功能作用”心脏结构和功能。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
岩田 裕子: "Stretch-induced cell damage in sarcoglycan-deficient myotubes"Pflugers Archiv. 442. 161-170 (2001)
Yuko Iwata:“肌聚糖缺陷型肌管中拉伸诱导的细胞损伤”Pflugers Archive。 442. 161-170 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 14 条
    Improvement of therapeutic methods for cardiomyopathy/heart failure based on the functional analysis of stretch-activated ion channel
    Pathophysiological role of TRPV2 as a therapeutic target for cardiomyopathy/heart failure
    The use of stable isotopic compositions for cannabis comparison
    The pathophysiological role of stretch activated channel(TRPV2) in cardiomypathy and heart failure
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
    • 批准号:
      31970691
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      张胜萍
    • 依托单位:
    TM9SF4调控非小细胞肺癌细胞凋亡机制研究
    • 批准号:
      31900527
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2019
    • 负责人:
      孙磊
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位: